Boom in unproven cell therapies intensifies regulatory debate

Heidi Ledford

Nature, 2016, vol. 537, issue 7619, 148-148

Abstract: Controversial US guidelines attempt to rein in rogue stem-cell clinics.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/537148a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:537:y:2016:i:7619:d:10.1038_537148a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/537148a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().